EP1414417A4 - Formulation pharmaceutique - Google Patents

Formulation pharmaceutique

Info

Publication number
EP1414417A4
EP1414417A4 EP00990878A EP00990878A EP1414417A4 EP 1414417 A4 EP1414417 A4 EP 1414417A4 EP 00990878 A EP00990878 A EP 00990878A EP 00990878 A EP00990878 A EP 00990878A EP 1414417 A4 EP1414417 A4 EP 1414417A4
Authority
EP
European Patent Office
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00990878A
Other languages
German (de)
English (en)
Other versions
EP1414417A1 (fr
Inventor
Abdul Rehman Khan
Kishan Vishwanth Kondawar
Arun Shriniwas Gosavi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GOSAVI ARUN SHRINIWASWOCKHARDT RESEARCH CENTRE
KONDAWAR KISHAN VISHWANTHWOCKHARDT RESEARCH CENTRE
GOSAVI ARUN SHRINIWASWOCKHARDT
KONDAWAR KISHAN VISHWANTHWOCKH
Original Assignee
GOSAVI ARUN SHRINIWASWOCKHARDT RESEARCH CENTRE
KONDAWAR KISHAN VISHWANTHWOCKHARDT RESEARCH CENTRE
GOSAVI ARUN SHRINIWASWOCKHARDT
KONDAWAR KISHAN VISHWANTHWOCKH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GOSAVI ARUN SHRINIWASWOCKHARDT RESEARCH CENTRE, KONDAWAR KISHAN VISHWANTHWOCKHARDT RESEARCH CENTRE, GOSAVI ARUN SHRINIWASWOCKHARDT, KONDAWAR KISHAN VISHWANTHWOCKH filed Critical GOSAVI ARUN SHRINIWASWOCKHARDT RESEARCH CENTRE
Publication of EP1414417A4 publication Critical patent/EP1414417A4/fr
Publication of EP1414417A1 publication Critical patent/EP1414417A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
EP00990878A 2000-12-01 2000-12-01 Formulation pharmaceutique Withdrawn EP1414417A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2000/000115 WO2002043707A1 (fr) 2000-12-01 2000-12-01 Formulation pharmaceutique

Publications (2)

Publication Number Publication Date
EP1414417A4 true EP1414417A4 (fr) 2004-05-06
EP1414417A1 EP1414417A1 (fr) 2004-05-06

Family

ID=11076282

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00990878A Withdrawn EP1414417A1 (fr) 2000-12-01 2000-12-01 Formulation pharmaceutique

Country Status (3)

Country Link
EP (1) EP1414417A1 (fr)
AU (1) AU2001230490A1 (fr)
WO (1) WO2002043707A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11576941B2 (en) 2016-06-21 2023-02-14 Laila Nutraceuticals Taste masking formulation for bitter natural compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4865851A (en) * 1987-05-14 1989-09-12 Glaxo Group Limited Pharmaceutical composition comprising cefuroxime axetil
WO2000030647A1 (fr) * 1998-11-26 2000-06-02 Biochemie Gesellschaft M.B.H. Compositions contenant du cefuroxime axetil

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US6210716B1 (en) * 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation
KR100342943B1 (ko) * 1999-08-04 2002-07-02 민경윤 비결정질 세푸록심 악세틸 고형분산체, 이의 제조 방법 및 이를 포함하는 경구투여용 조성물

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4865851A (en) * 1987-05-14 1989-09-12 Glaxo Group Limited Pharmaceutical composition comprising cefuroxime axetil
WO2000030647A1 (fr) * 1998-11-26 2000-06-02 Biochemie Gesellschaft M.B.H. Compositions contenant du cefuroxime axetil

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0243707A1 *

Also Published As

Publication number Publication date
WO2002043707A1 (fr) 2002-06-06
AU2001230490A1 (en) 2002-06-11
EP1414417A1 (fr) 2004-05-06

Similar Documents

Publication Publication Date Title
IL156716A0 (en) Pharmaceutical formulation
GB0118689D0 (en) Pharmaceutical formulation
PL366432A1 (en) Pharmaceutical formulation
PL366067A1 (en) Oxayolidinone tablet formulation
GB9909154D0 (en) Pharmaceutical formulation
GB0014851D0 (en) Novel pharmaceutical formulation
GB9926251D0 (en) Pharmaceutical formulation
GB0014947D0 (en) Novel pharmaceutical formulation
GB0014883D0 (en) Novel pharmaceutical formulation
GB0014892D0 (en) Novel pharmaceutical formulation
GB0014869D0 (en) Novel pharmaceutical formulation
GB0021487D0 (en) Pharmaceutical
EP1414417A4 (fr) Formulation pharmaceutique
GB0104749D0 (en) Pharmaceutical formulation
GB0014849D0 (en) Pharmaceutical aerosol formulation
GB0019084D0 (en) Pharmaceutical formulation
GB0018654D0 (en) Pharmaceutical formulation
GB0018686D0 (en) Pharmaceutical formulation
GB0014451D0 (en) Pharmaceutical formulation
GB0014424D0 (en) Pharmaceutical formulation
GB0019840D0 (en) Novel pharmaceutical formulation
GB0014881D0 (en) Pharmaceutical aerosol formulation
GB0002691D0 (en) Pharmaceutical composition
GB0124712D0 (en) Pharmaceutical formulation
GB9910633D0 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030618

A4 Supplementary search report drawn up and despatched

Effective date: 20040224

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070424